Resveratrol clinical trials
Also written resVida and BIA 6-512.
How each study uses Resveratrol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Resveratrol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
133 studies that test it; most in 2011 (13)
| Year | Studies |
|---|---|
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 9 |
| 2014 | 9 |
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 2 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 124
Northumbria University (9) · Bial - Portela C S.A. (7) · Maastricht University Medical Center (6) · University of Aarhus (5) · National Cancer Institute (NCI) (4) · Khyber Medical University Peshawar (3) · University of Florida (3) · InCor Heart Institute (3)
Often tested with
Tested in the same studies.
Curcumin (4) · Urtica dioica (2) · Ascorbic Acid (2) · Thioctic Acid (2) · Chenodeoxycholic Acid (1) · Atorvastatin (1) · Quercetin (1) · Concord grape juice (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Resveratrol.
- Jan 2027Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1Early Phase 1 · Augusta University
- Jul 2027Strength Training and ResveratrolNot applicable · Texas Tech University
- Oct 2027Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen PlanusPhase 2 · University of Palermo
Studies
Open first, then newest update. How each study uses Resveratrol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 133
- Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol SupplementationRecruitingNot applicableInCor Heart InstituteNCT07865377Written as Trans-resveratrol, 1000 mg daily for 90 daysHow we know
- RESvEraTrol in Parkinson's Disease (RESET)RecruitingPhase 2Georgetown UniversityNCT07592767Written as Trans-ResveratrolHow we know
- Strength Training and ResveratrolRecruitingNot applicableTexas Tech UniversityNCT06585865Written as Resveratrol 500 mg oral once daily.How we know
- Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen PlanusRecruitingPhase 2University of PalermoNCT07100613Written as Clobetasol + Resveratrol PatchHow we know
- Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face StudyNot yet recruitingNot applicableAssiut UniversityNCT07060157Written as resveratrol 1 % gelHow we know
- Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.RecruitingPhase 3Al-Mustansiriyah UniversityNCT06882564Written as resveratrol mouthwashHow we know
- Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1RecruitingEarly Phase 1Augusta UniversityNCT04449198Written as ResveratrolHow we know
- Effects of Resveratrol Supplementation on Oocyte QualityNot yet recruitingNot applicableCentro Hospitalar e Universitário de Coimbra, E.P.E.NCT06235294Written as ResveratrolHow we know
- The Effects of Resveratrol on Sirtuins and Apoptosis BiomarkersRecruitingNot applicableInCor Heart InstituteNCT05808387Written as ResveratrolHow we know
- Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWICompletedNot applicableUniversity of Alabama at BirminghamNCT05377242Written as ResveratrolHow we know
- Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 DiabetesCompletedNot applicableUniversitas SriwijayaNCT07569744Written as ResveratrolHow we know
- Resveratrol for the Prevention of Bone Loss in Postmenopausal WomenCompletedNot applicableUniversity of DelawareNCT06250283Written as ResveratrolHow we know
- Resveratrol in Knee OsteoarthritisCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02905799Written as oral resveratrolHow we know
- Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5CompletedPhase 2Institut National de la Santé Et de la Recherche Médicale, FranceNCT02314208Written as ResveratrolHow we know
- A Study to Evaluate the Safety and Efficacy of RQC for AMDCompletedPhase 2Paul A Knepper, MD PhDNCT05062486Written as Resveratrol, Quercetin, Curcumin (RQC)How we know
- Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic FibrosisCompletedEarly Phase 1Virginia Commonwealth UniversityNCT04166396Written as ResveratrolHow we know
- Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin ResistanceCompletedNot applicableInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNCT06961279Written as ResveratrolHow we know
- Study of High-Dose Resveratrol in Patients With Stable Ischemic Heart DiseaseCompletedNot applicableS.LAB (SOLOWAYS)NCT06914934Written as High-dose resveratrol 500 mg/dayHow we know
- Short Interval Resveratrol Trial in Cardiovascular SurgeryActive, not recruitingNot applicableMaineHealthNCT03762096Written as Trans-resveratrolHow we know
- Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)CompletedPhase 1Icahn School of Medicine at Mount SinaiNCT04421079Written as Trans-resveratrolHow we know
See all 133 studies that test Resveratrol →
Given beside what is tested · 2 — Resveratrol is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Resveratrol
- Pilot Study to Evaluate the Plasma Profile of RevifastCompletedNot applicableBernard FiorettiNCT04258306Written as pure resveratrolHow we know
- Resveratrol With or Without Piperine to Enhance Plasma Levels of ResveratrolCompletedNot applicableUniversity of Wisconsin, MadisonNCT01324089Written as ResveratrolHow we know
- Pharmacokinetics of Resveratrol Comprising ProductsCompletedNot applicableFruitura Bioscience Ltd.NCT01747252Written as ResveratrolHow we know
Codes
What other systems call Resveratrol · ClinicalTrials.gg INT006657
- MeSH (NLM) D000077185ResveratrolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Q369O8926LRESVERATROLConfirmed FDA, NLM, Wikidata
- RxNorm 1000492Confirmed FDA, Wikidata
- Wikidata Q407329resveratrolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1215ResveratrolOne source FDA
- DrugBank DB02709One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077185 | Resveratrol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Q369O8926L | RESVERATROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1000492 | — | Confirmed FDA, Wikidata |
| Wikidata | Q407329 | resveratrol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1215 | Resveratrol | One source FDA |
| DrugBank | DB02709 | — | One source Wikidata |
Also registered as resveratrol, (z)- (UNII AUA0K06FSB).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.